Decline in breast cancer: Not just because of hormone therapy
Between 2002 and 2003, American women experienced a 7 percent decline in breast cancer incidence, which scientists attribute to the publicity surrounding results of the Women's Health Initiative (WHI). However, researchers led by Brian Sprague, Ph.D. have conducted a reevaluation of the post-WHI landscape that suggests otherwise.
"We found that the change in hormone therapy use only accounted for a decline of about 3 percent, so there's another 4 percent that is being caused by something we do not yet know," said Sprague, a postdoctoral fellow at the University of Wisconsin.
Results of this study were presented at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference, held Dec. 6-9 in Houston.
In 1991, the National Institutes of Health established the WHI to address the most common causes of death, disability and deterred quality of life among 15,730 postmenopausal women — cancer, cardiovascular disease and osteoporosis.
Results of the WHI demonstrated in 2002 that hormone therapy is linked with an increased risk of breast cancer. Other studies have confirmed this relationship, and many women have stopped taking hormone therapy due to concerns about the potential risk of cancer. At the same time, the incidence of breast cancer has declined, which researchers attribute to the decrease in hormone therapy use.
After conducting a thorough literature review of the decline in hormone use and the decline in breast cancer incidence, Sprague and colleagues estimated that 42 percent of the decline in incidence of breast cancer was linked to the cessation of hormone therapy use.
Sprague said that additional studies are needed to determine the source of the remaining decline in breast cancer cases.
"This does not mean that women should start taking hormones again, but there appear to be additional factors that have contributed to the decline in breast cancer," he said.
Source: American Association for Cancer Research
Articles on the same topic
- Novel detection method unmasks circulating breast cancer cellsSat, 12 Dec 2009, 1:24:17 UTC
- Clinical trial advances new approach to re-sensitizing breast cancerFri, 11 Dec 2009, 23:59:12 UTC
- Targeted therapy prolongs life in patients with HER2-positive breast cancerFri, 11 Dec 2009, 18:59:03 UTC
- Disease-free, overall survival inferior for black women with HR-positive breast cancerFri, 11 Dec 2009, 18:27:43 UTC
- Anti-estrogens may offer protection against lung cancer mortalityFri, 11 Dec 2009, 16:44:58 UTC
- A new mouse could help understand how some lung cancer cells evade drug treatmentWed, 9 Dec 2009, 5:24:07 UTC
- Tiny RNA has big impact on lung cancer tumorsMon, 7 Dec 2009, 12:08:11 UTC
Other sources
- Anti-estrogens may offer protection against lung cancer mortalityfrom Science DailyMon, 14 Dec 2009, 4:14:17 UTC
- Clinical trial advances new approach to re-sensitizing breast cancerfrom PhysorgSun, 13 Dec 2009, 18:56:11 UTC
- Clinical trial advances new approach to re-sensitizing breast cancerfrom Science DailySun, 13 Dec 2009, 5:14:07 UTC
- Novel detection method unmasks circulating breast cancer cellsfrom Science BlogSat, 12 Dec 2009, 1:21:13 UTC
- Anti-estrogens may offer protection against lung cancer mortalityfrom Science BlogFri, 11 Dec 2009, 21:56:31 UTC
- Disease-free, overall survival inferior for black women with HR-positive breast cancerfrom Science BlogFri, 11 Dec 2009, 21:56:27 UTC
- Targeted therapy prolongs life in patients with HER2-positive breast cancerfrom Science BlogFri, 11 Dec 2009, 21:56:11 UTC
- Targeted therapy prolongs life in patients with HER2-positive breast cancerfrom PhysorgFri, 11 Dec 2009, 21:28:06 UTC
- Targeted therapy prolongs life in patients with HER2-positive breast cancerfrom Science DailyFri, 11 Dec 2009, 21:21:13 UTC
- Most Oncologists Feel New Genetic Test for Tamoxifen Sensitivity Not Ready for the Clinicfrom PhysorgFri, 11 Dec 2009, 20:14:52 UTC
- Targeted therapy prolongs life in patients with HER2-positive breast cancerfrom Science BlogFri, 11 Dec 2009, 20:07:16 UTC
- Disease-free, overall survival inferior for black women with HR-positive breast cancerfrom Science BlogFri, 11 Dec 2009, 18:56:28 UTC
- Disease-free, overall survival inferior for black women with HR-positive breast cancerfrom PhysorgFri, 11 Dec 2009, 18:21:53 UTC
- Anti-estrogens may offer protection against lung cancer mortalityfrom PhysorgFri, 11 Dec 2009, 17:35:25 UTC
- Anti-estrogens may offer protection against lung cancer mortalityfrom Science BlogFri, 11 Dec 2009, 17:21:25 UTC
- Decline of hormone therapy decreases breast cancer cases, analysis findsfrom PhysorgWed, 9 Dec 2009, 23:14:17 UTC
- New mouse could help understand how some lung cancer cells evade drug treatmentfrom Science DailyWed, 9 Dec 2009, 15:45:13 UTC
- A new mouse could help understand how some lung cancer cells evade drug treatmentfrom PhysorgWed, 9 Dec 2009, 10:49:14 UTC
- A new mouse could help understand how some lung cancer cells evade drug treatmentfrom Science BlogWed, 9 Dec 2009, 6:07:21 UTC
- Decline in breast cancer: Not just because of hormone therapyfrom PhysorgTue, 8 Dec 2009, 11:07:07 UTC
- Tiny RNA has big impact on lung cancer tumorsfrom Biology News NetMon, 7 Dec 2009, 23:56:37 UTC
- Tiny RNA has big impact on lung cancer tumorsfrom Science DailyMon, 7 Dec 2009, 17:14:30 UTC
- Tiny RNA has big impact on lung cancer tumorsfrom Science BlogMon, 7 Dec 2009, 12:49:16 UTC
- Tiny RNA has big impact on lung cancer tumorsfrom PhysorgMon, 7 Dec 2009, 12:07:06 UTC